Burn injury disrupts the skin’s primary protective barrier, exposing underlying tissues to a diverse microbial milieu and creating a niche for rapid colonisation and infection. Management begins with ...
A late-stage clinical trial found that a topical spray called peceleganan (PL-5) helped adults with mild infected burn wounds ...
SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize ...
Hospital-onset bacteremia is common in burn patients—and often tied to burn severity and surgical wound care, not lapses in quality. New data suggest that HOB may be a poor standalone quality metric ...
Serious burn victims are immunocompromised and may be missing skin on parts of their body, and this makes them highly vulnerable to bacteria. Thanks to progress in intensive care, they are ...
A phase IIIb trial found that the antimicrobial peptide spray peceleganan (PL-5) significantly improved complete healing and bacterial clearance in mild infected burn wounds without systemic ...
A new mouse study shows that non-viable probiotic cells, or paraprobiotics, can suppress bacterial virulence factors and ...
Discover how wise leadership in infection control transforms challenges into opportunities, fosters teamwork, and safeguards patient safety through emotional intelligence, strategic vision, and ...
See more Winnipeg Sun on Google - pleasesave as a Preferred Source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results